Fem1b Inhibitors

Abstract:

UC Berkeley researchers have discovered novel, specific Fem1b inhibitors. Fem1b is essential in lymphoma and lung cancer cells. Fem1b inhibition could be beneficial in cancer, metabolic disease, obesity, diabetes, and other diseases.

Website:

https://techtransfer.universityofcalifornia.edu/NCD/32345.html?utm_source=AUTMGTP&utm_medium=webpage&utm_term=ncdid_32345&utm_campaign=TechWebsites

Potential Applications:

therapeutics

Additional Information:

Tech ID/UC Case

32345/2021-139-0

Related Cases

2021-139-0

Contact Information:

  • Name: Terri Sale
  • Title :
  • Department :
  • Email: terri.sale@berkeley.edu
  • Phone: 510-643-4219
  • Address :